Abstract

HLA class II (HLA-II) genes’ polymorphism influences the immune response to Chlamydia trachomatis (Ct), it is considered a sexually transmitted infection. However, associations between HLA-II alleles and Ct-infection have been little explored in humans; this study was thus aimed at determining HLA-DRB1-DQB1 alleles/haplotypes’ effect on Ct-infection outcome in a cohort of Colombian women. Cervical sample DNA was used as template for detecting Ct by PCR and typing HLA-DRB1-DQB1 alleles/haplotypes by Illumina MiSeq sequencing. Survival models were adjusted for identifying the alleles/haplotypes’ effect on Ct-outcome; bioinformatics tools were used for predicting secreted bacterial protein T- and B-cell epitopes. Sixteen HLA-DRB1 alleles having a significant effect on Ct-outcome were identified in the 262 women analysed. DRB1*08:02:01G and DRB1*12:01:01G were related to infection-promoting events. Only the DQB1*05:03:01G allele related to clearance/persistence events was found for HLA-DQB1. HLA-DRB1 allele homozygous women were associated with events having a lower probability of clearance and/or early occurrence of persistence. Twenty-seven peptides predicted in silico were associated with protective immunity against Ct; outer membrane and polymorphic membrane protein-derived peptides had regions having dual potential for being T- or B-cell epitopes. This article describes HLA-DRB1-DQB1 alleles/haplotypes related to Ct-infection resolution and the peptides predicted in silico which might probably be involved in host immune response. The data provides base information for developing future studies leading to the development of effective prevention measures against Ct-infection.

Details

Title
Identifying HLA DRB1-DQB1 alleles associated with Chlamydia trachomatis infection and in silico prediction of potentially-related peptides
Author
Pedraza Leidy 1 ; Camargo Milena 2 ; Moreno-Pérez, Darwin A 2 ; Sánchez, Ricardo 3 ; Del Río-Ospina Luisa 4 ; Báez-Murcia, Indira M 4 ; Patarroyo, Manuel E 5 ; Patarroyo, Manuel A 5 

 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad Nacional de Colombia, MSc Programme in Microbiology, Bogotá D.C., Colombia (GRID:grid.10689.36) (ISNI:0000 0001 0286 3748) 
 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Animal Science Faculty, Bogotá D.C., Colombia (GRID:grid.442162.7) (ISNI:0000 0000 8891 6208) 
 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad Nacional de Colombia, Faculty of Medicine, Bogotá D.C., Colombia (GRID:grid.10689.36) (ISNI:0000 0001 0286 3748) 
 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527) 
 Fundación Instituto de Inmunología de Colombia (FIDIC), Molecular Biology and Immunology Department, Bogotá D.C., Colombia (GRID:grid.418087.2) (ISNI:0000 0004 0629 6527); Universidad Nacional de Colombia, Faculty of Medicine, Bogotá D.C., Colombia (GRID:grid.10689.36) (ISNI:0000 0001 0286 3748); Main Campus, Universidad Santo Tomás, Health Sciences Division, Bogotá D.C., Colombia (GRID:grid.442190.a) (ISNI:0000 0001 1503 9395) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2542529694
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.